ArticleBMC pulmonary medicine2026

Haemodynamic and clinical impacts of switching phosphodiesterase-5 inhibitors to riociguat in patients with chronic thromboembolic pulmonary hypertension (CTEPH) after balloon pulmonary angioplasty (BPA) - a prospective cohort study.

Timothy Ho Him Kam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.